Arthritis	O	0,9
is	O	10,12
a	O	13,14
late	B-KP	15,19
manifestation	I-KP	20,33
of	I-KP	34,36
Lyme	I-KP	37,41
disease	I-KP	42,49
,	O	49,50
usually	O	51,58
beginning	O	59,68
months	O	69,75
after	O	76,81
the	O	82,85
tick	O	86,90
bite	O	91,95
.	O	95,96

However	O	97,104
,	O	104,105
a	O	106,107
history	O	108,115
of	O	116,118
erythema	B-KP	119,127
migrans	I-KP	128,135
or	O	136,138
tick	O	139,143
bite	O	144,148
may	O	149,152
be	O	153,155
lacking	O	156,163
.	O	163,164

Patients	O	165,173
have	O	174,178
intermittent	O	179,191
or	O	192,194
persistent	O	195,205
attacks	O	206,213
of	O	214,216
joint	O	217,222
swelling	O	223,231
and	O	232,235
pain	O	236,240
,	O	240,241
primarily	O	242,251
in	O	252,254
one	O	255,258
or	O	259,261
a	O	262,263
few	O	264,267
large	O	268,273
joints	O	274,280
,	O	280,281
often	O	282,287
the	O	288,291
knee	O	292,296
,	O	296,297
during	O	298,304
a	O	305,306
period	O	307,313
of	O	314,316
months	O	317,323
to	O	324,326
several	O	327,334
years	O	335,340
,	O	340,341
with	O	342,346
few	O	347,350
systemic	O	351,359
manifestations	O	360,374
.	O	374,375

The	O	376,379
diagnosis	O	380,389
is	O	390,392
established	O	393,404
by	O	405,407
two-tier	B-KP	408,416
serologic	I-KP	417,426
testing	I-KP	427,434
for	O	435,438
B	B-KP	439,440
.	I-KP	440,441
burgdorferi	I-KP	442,453
by	O	454,456
ELISA	B-KP	457,462
and	O	463,466
IgG	B-KP	467,470
Western	I-KP	471,478
blotting	I-KP	479,487
,	O	487,488
which	O	489,494
typically	O	495,504
shows	O	505,510
strong	O	511,517
responses	O	518,527
to	O	528,530
many	O	531,535
spirochetal	B-KP	536,547
proteins	I-KP	548,556
with	O	557,561
many	O	562,566
bands	O	567,572
present	O	573,580
.	O	580,581

PCR	B-KP	582,585
testing	I-KP	586,593
of	O	594,596
synovial	O	597,605
fluid	O	606,611
for	O	612,615
B	B-KP	616,617
.	I-KP	617,618
burgdorferi	I-KP	619,630
DNA	I-KP	631,634
is	O	635,637
often	O	638,643
positive	O	644,652
prior	O	653,658
to	O	659,661
antibiotic	B-KP	662,672
therapy	I-KP	673,680
,	O	680,681
but	O	682,685
the	O	686,689
test	O	690,694
is	O	695,697
not	O	698,701
a	O	702,703
reliable	O	704,712
indicator	O	713,722
of	O	723,725
spirochetal	B-KP	726,737
eradication	I-KP	738,749
following	I-KP	750,759
antibiotic	I-KP	760,770
treatment	I-KP	771,780
,	O	780,781
since	O	782,787
spirochetal	B-KP	788,799
DNA	I-KP	800,803
may	O	804,807
persist	O	808,815
after	O	816,821
spirochetal	O	822,833
killing	O	834,841
.	O	841,842

Initial	O	843,850
recommended	O	851,862
therapies	O	863,872
include	O	873,880
a	O	881,882
30-day	O	883,889
course	O	890,896
of	O	897,899
oral	B-KP	900,904
doxycycline	I-KP	905,916
or	O	917,919
amoxicillin	B-KP	920,931
.	O	931,932

However	O	933,940
,	O	940,941
for	O	942,945
patients	O	946,954
with	O	955,959
persistent	O	960,970
joint	O	971,976
swelling	O	977,985
despite	O	986,993
oral	B-KP	994,998
therapy	I-KP	999,1006
,	O	1006,1007
IV	B-KP	1008,1010
ceftriaxone	I-KP	1011,1022
for	O	1023,1026
2	O	1027,1028
to	O	1029,1031
4	O	1032,1033
weeks	O	1034,1039
may	O	1040,1043
be	O	1044,1046
needed	O	1047,1053
for	O	1054,1057
successful	O	1058,1068
treatment	O	1069,1078
.	O	1078,1079

A	O	1080,1081
small	O	1082,1087
percentage	O	1088,1098
of	O	1099,1101
patients	O	1102,1110
may	O	1111,1114
have	O	1115,1119
persistent	O	1120,1130
arthritis	O	1131,1140
for	O	1141,1144
months	O	1145,1151
or	O	1152,1154
several	O	1155,1162
years	O	1163,1168
after	O	1169,1174
both	O	1175,1179
oral	B-KP	1180,1184
and	I-KP	1185,1188
IV	I-KP	1189,1191
antibiotic	I-KP	1192,1202
therapy	I-KP	1203,1210
,	I-KP	1210,1211
which	O	1212,1217
may	O	1218,1221
be	O	1222,1224
treated	O	1225,1232
successfully	O	1233,1245
with	O	1246,1250
anti-inflammatory	B-KP	1251,1268
agents	I-KP	1269,1275
,	O	1275,1276
DMARDs	B-KP	1277,1283
,	O	1283,1284
or	O	1285,1287
synovectomy	B-KP	1288,1299
.	O	1299,1300

The	O	1301,1304
antibody	B-KP	1305,1313
response	O	1314,1322
to	O	1323,1325
B	B-KP	1326,1327
.	I-KP	1327,1328
burgdorferi	I-KP	1329,1340
declines	O	1341,1349
slowly	O	1350,1356
after	O	1357,1362
treatment	O	1363,1372
,	O	1372,1373
but	O	1374,1377
the	O	1378,1381
test	O	1382,1386
typically	O	1387,1396
remains	O	1397,1404
positive	O	1405,1413
for	O	1414,1417
years	O	1418,1423
after	O	1424,1429
therapy	O	1430,1437
.	O	1437,1438

